Skip to main content
Close
Publication

Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.

See all publications
Not available in
This is not available in . You can go to the translated versions in these languages: